A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants

  1. Martinon-Torres, F.
  2. Gimenez-Sanchez, F.
  3. Bernaola-Iturbe, E.
  4. Diez-Domingo, J.
  5. Jiang, Q.
  6. Perez, J.L.
Journal:
Vaccine

ISSN: 1873-2518,  0264-410X

Year of publication: 2014

Volume: 32

Issue: 40

Pages: 5206-5211

Type: Article

DOI: 10.1016/J.VACCINE.2014.07.049 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus